The Predictive Value of the Serum Digoxin Concentration in the Management of Hospitalized Patients

Publisher Website
Google Scholar
Abstract
Serum digoxin concentration (SDC) was compared with clinical and ancillary predictors as a guide to adjustment of digoxin dose and as a test for digitalis toxicity in a total of 76 hospitalized patients during a period of 9 months. The mean SDC (3.6 ± 2.5 nmoles/liter) associated with unexpected discontinuation of therapy was significantly higher (p < 0.001) than that (1.1 ± 0.6 nmoles/liter) associated with unaltered digoxin dose, while the mean SDC (0.6 ± 0.4 nmole/liter) associated with unexpected dose increase was significantly lower (p < 0.05). There was no significant association between other pharmacokinetic or pharmacodynamic predictors and therapeutic intention. There was a 13% incidence of confirmed digitalis intoxication. The mean SDC (3.6 ± 1.9 nmoles/liter) of patients presenting and confirmed as digitalis toxic was significantly higher (p < 0.001) than that (1.4 ± 0.6 nmoles/liter) involving a situation in which digitalis toxicity could not initially be excluded by other means. The predictive value of an SDC ≥ 2.6 nmoles/liter for toxicity was 80%, and its efficiency for diagnosing both toxicity and nontoxicity was 95%. The SDC was thus shown to be a valid test of digitalis toxicity and to provide extraordinary information enabling the clinician to modulate digoxin therapy precisely.